Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 58Colonic Neoplasms 24Rectal Neoplasms 22Neoplasms 19Pancreatic Neoplasms 18Neoplasm Metastasis 17Esophageal Neoplasms 9Stomach Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Sarcoma 6Small Cell Lung Carcinoma 5Lung Neoplasms 5Glioma 5Glioblastoma 5Brain Neoplasms 5Neuroblastoma 4Gliosarcoma 4Esophageal Squamous Cell Carcinoma 4Carcinoma, Renal Cell 4Melanoma 3Intestinal Neoplasms 3Gastrointestinal Neoplasms 3Breast Neoplasms 3Adenocarcinoma Of Esophagus 3Adenocarcinoma 3Sarcoma, Ewing 2Recurrence 2Rectal Diseases 2Ovarian Neoplasms 2Oligodendroglioma 2

Interventions

Cyclophosphamide 9fludarabine 8Interleukin-2 8aldesleukin 7Sunitinib 6Everolimus 6Bevacizumab 6fludarabine phosphate 5Sorafenib 5Radiotherapy 4Nivolumab 4Gene Expression Profiling 4Filgrastim 4pembrolizumab 3peginterferon alfa-2b 3Stem Cell Transplantation 3Radiotherapy, Intensity-Modulated 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Immunohistochemistry 3Granulocyte Colony-Stimulating Factor 3cabozantinib 2atezolizumab 2Thiotepa 2Sodium Chloride 2Reverse Transcriptase Polymerase Chain Reaction 2Polymerase Chain Reaction 2Mycophenolic Acid 2Mesna 2Immunoenzyme Techniques 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Kidney Neoplasms × Irinotecan × Clear all
NCT00089102 2018-07-16

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer

Medical University of South Carolina

Phase 2 Terminated
9 enrolled 8 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡